Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.410
-0.080 (-3.21%)
At close: Nov 20, 2024, 4:00 PM
2.580
+0.170 (7.05%)
Pre-market: Nov 21, 2024, 7:33 AM EST
Lipella Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 6 | 18 | - | - | - |
| Market Cap Growth | -55.60% | -67.07% | - | - | - | - |
| Enterprise Value | 2 | 4 | 18 | - | - | - |
| Last Close Price | 2.41 | 8.16 | 25.04 | - | - | - |
| PS Ratio | 4.77 | 13.17 | 97.63 | - | - | - |
| PB Ratio | 1.80 | 1.88 | 3.85 | - | - | - |
| P/TBV Ratio | 2.62 | 1.88 | 3.85 | - | - | - |
| EV/Sales Ratio | 3.37 | 8.16 | 98.33 | - | - | - |
| Debt / Equity Ratio | 0.05 | 0.04 | 0.09 | 0.20 | 0.72 | -0.85 |
| Asset Turnover | 0.19 | 0.09 | 0.05 | 0.17 | 1.79 | - |
| Quick Ratio | 1.97 | 8.63 | 4.44 | 5.03 | 3.25 | 0.66 |
| Current Ratio | 2.97 | 8.90 | 4.92 | 5.31 | 3.37 | 0.72 |
| Return on Equity (ROE) | -231.67% | -118.13% | -85.18% | -197.73% | -35.75% | - |
| Return on Assets (ROA) | -108.95% | -62.27% | -40.65% | -80.69% | -6.62% | - |
| Return on Capital (ROIC) | -139.38% | -70.74% | -47.52% | -95.73% | -9.15% | - |
| Earnings Yield | -146.33% | -78.02% | -14.45% | - | - | - |
| FCF Yield | -126.58% | -53.46% | -10.19% | - | - | - |
| Buyback Yield / Dilution | -41.54% | -47.84% | -19.15% | -59.91% | -2.46% | - |
| Total Shareholder Return | -41.54% | -47.84% | -19.15% | -59.91% | -2.46% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.